MOKAN Wealth Management Inc.

Position in MRK — Merck & Co., Inc.

CIK 2053727 OVERLAND PARK, KS

Position in MRK

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$6,295,215

+$1,129,722 QoQ

Shares Held

48,990

+14.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

3.28%

of 13F equity value

Holder Rank

#940

of 3,769 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 8% None 92%

Healthcare · as of Jun 30, 2026

MOKAN Wealth Management Inc. holds $20,473,093 across 6 Drug Manufacturers - General names. MRK ranks #1 (30.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	48,990	$6,295,215
2	ABBV	AbbVie Inc.	23,835	$5,997,839
3	LLY	ELI LILLY & Co	4,208	$5,047,201
4	JNJ	Johnson & Johnson	5,872	$1,491,311
5	GILD	Gilead Sciences, Inc.	10,399	$1,313,809
6	AMGN	Amgen Inc	905	$327,718

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,295,215	48,990	+14.1%	Shares	Sole	2026-07-28
2026-03-31	$5,165,493	42,942	-7.0%	Shares	Sole	2026-05-01
2025-12-31	$4,858,275	46,155	-9.4%	Shares	Sole	2026-01-26
2025-09-30	$4,275,394	50,940	-14.2%	Shares	Sole	2025-10-30
2025-06-30	$4,701,233	59,389	+32.5%	Shares	Sole	2025-07-25
2025-03-31	$4,023,132	44,821	+13.8%	Shares	Sole	2025-04-23
2024-12-31	$3,919,014	39,395	—	Shares	Sole	2025-01-30
No filing history on record for this holder in this stock.